Selective inhibitors of 11beta-hydroxysteroid dehydrogenase type 1 for patients with metabolic syndrome: is the target liver, fat, or both?
Päätekijät: | Stewart, P, Tomlinson, J |
---|---|
Aineistotyyppi: | Journal article |
Kieli: | English |
Julkaistu: |
2009
|
Samankaltaisia teoksia
-
Cortisol metabolism and the role of 11beta-hydroxysteroid dehydrogenase.
Tekijä: Tomlinson, J, et al.
Julkaistu: (2001) -
Cortisol, 11 beta-hydroxysteroid dehydrogenase type 1 and central obesity.
Tekijä: Stewart, P, et al.
Julkaistu: (2002) -
The functional consequences of 11beta-hydroxysteroid dehydrogenase expression in adipose tissue.
Tekijä: Tomlinson, J, et al.
Julkaistu: (2002) -
The role of 11 beta-hydroxysteroid dehydrogenase in central obesity and osteoporosis.
Tekijä: Tomlinson, J, et al.
Julkaistu: (2000) -
Mechanisms of disease: Selective inhibition of 11beta-hydroxysteroid dehydrogenase type 1 as a novel treatment for the metabolic syndrome.
Tekijä: Tomlinson, J, et al.
Julkaistu: (2005)